Clinical Trials Logo

Proctocolitis clinical trials

View clinical trials related to Proctocolitis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06088537 Recruiting - Clinical trials for Isolated Rectal Bleedings

Isolated Rectal Bleeding in Newborns : Allergic Proctocolitis or Neonatal Colitis Transient - COLON Study

COLON
Start date: January 24, 2024
Phase:
Study type: Observational

Prospective observational pilot study evaluating the frequency of cow's milk protein allergic prococolitis in newborns hospitalized in neontal medicine at the university hospital of Nice who presented rectal bleeding.

NCT ID: NCT05793112 Recruiting - Infant Development Clinical Trials

INF108F in Infants With Food Protein Induced Proctocolitis

RESTORE
Start date: September 9, 2023
Phase: Phase 4
Study type: Interventional

Single-center, randomized, double-blind, placebo-controlled trail evaluating INF108F in breastfed infants with FPIAP

NCT ID: NCT05099653 Recruiting - Clinical trials for Crohn Disease Haemorrhagic Rectocolitis

Study of the Impact of a Physical Activity Programme on the Quality of Life of Patients With Inflammatory Bowel Disease

APMICI
Start date: February 20, 2020
Phase: N/A
Study type: Interventional

Regular physical activity at a mild to moderate intensity can control inflammation in general and intestinal inflammation in particular during IBD. The effectiveness of a physical activity programme has been evaluated during IBD, but the data are limited to a few studies. Overall, PA improves quality of life but also improves control of disease symptoms and fatigue . The aim of the present work is to evaluate the impact of a physical activity programme on quality of life in patients with IBD. This programme will also evaluate the impact of physical activity on 1) anxiety-depression, 2) fatigue (a frequent and difficult to manage symptom in IBD), 3) IBD activity, 4) smoking cessation.

NCT ID: NCT04462978 Recruiting - Clinical trials for Food Protein-Induced Enterocolitis Syndrome

Non-Immunoglobulin E-mediated Food Allergies in Children

NIGEFA
Start date: January 1, 2017
Phase:
Study type: Observational

Non-IgE-mediated gastrointestinal food allergies (non-IgE-GIFA) are an evolving web of clinical conditions characterized by subacute and/or chronic symptoms and include food protein-induced enterocolitis syndrome (FPIES), food protein-induced enteropathy (FPE), food protein-induced allergic proctocolitis (FPIAP), and food protein-induced allergic dysmotility disorders (gastroesophageal reflux disease (GERD), colic and constipation) (FPIMD). Despite the prevalence and clinical impact of these conditions, the pathogenesis as well as the natural history and the best management of these disorders are still poorly defined. These limitations could be responsible for diagnostic delays and errors, and suboptimal clinical management. We aim to evaluate clinical features, natural course and pathophysiology of non-IgE-GIFA in the pediatric age.